RAF265
RAF265 (CHIR-265) is a potent dual inhibitor targeting Raf kinases (C-Raf, B-Raf, B-Raf V600E) and VEGFR2, with IC50 values in the low nanomolar range. This compound has been investigated in Phase 2 clinical studies for oncology research, supporting its use in both in vitro biochemical assays and in vivo models of cancer and angiogenesis.
Product Specifications
CAS Number
927880-90-8
Product Name Alternative
Raf, Raf kinases, RAF 265, RAF265, RAF-265, VEGFR, VEGFR2, Vascular endothelial growth factor receptor, Inhibitor, inhibit, CHIR 265, CHIR265, CHIR-265, Autophagy, Apoptosis, B-Raf
Field of Research
Cardiovascular Research, Cell Biology, Signal Transduction
Purity
99.18% (May vary between batches)
Solubility
Ethanol:10.4 mg/mL (20.06 mM) ; DMSO:51.8 mg/mL (99.92 mM)
Smiles
Cn1c (Nc2ccc (cc2) C (F) (F) F) nc2cc (Oc3ccnc (c3) -c3ncc ([nH]3) C (F) (F) F) ccc12
Molecular Formula
C24H16F6N6O
Molecular Weight
518.41
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
ST61A0150C Box of 100
Box of 100 Discs of Standard Filter 73G/M², 150 Mm
Sign In for Pricing
View Details 
MBS6355639-01 0.2 mL
TIMP3, ID (TIMP3, Metalloproteinase inhibitor 3, Protein MIG-5, Tissue inhibitor of metalloproteinases 3) (Azide free) (HRP)
Sign In for Pricing
View Details MBS6355639-02 5x 0.2 mL
TIMP3, ID (TIMP3, Metalloproteinase inhibitor 3, Protein MIG-5, Tissue inhibitor of metalloproteinases 3) (Azide free) (HRP)
Sign In for Pricing
View Details 